On March 25, 2018, LifeTech invited Prof. Huang who comes from the Department of Cardiovascular Medicine at the People's Hospital of Wuhan University to provide theoretical and animal procedure training of the LAmbre™ LAA closure system
From January 31st to February 3rd, 2018, CSI Asia-Pacific 2018 was held in Ho Chi Minh City, Vietnam. LifeTech was invited to the academic event and conducted a series of academic activities such as satellite meetings and live procedures.
From January 19 to 21, 2018, the "Senior Training in and Live Global Surgical Demonstration of Left Atrial Appendage Closure & the Kickoff Meeting for the Builder of the China Atrial Fibrillation Center" was successfully held in the Shanghai Tenth People's Hospital.
On January 10, 2017, LifeTech, Ally Bridge Group and Morrison & Foerster joined hands to hold a forum on medical technology cooperation in China, in San Francisco，United States during the J.P.Mprgan Healthcare Conference.
In January 7, 2018, LifeTech Scientific Corporation has entered into a strategic partnership with Ally Bridge Group (“ABG”), a global healthcare-focused investment firm.
Lifetech Scientific (Shenzhen) Co. Ltd is pleased to announce that its HeartTone™ implantable cardiac pacemaker has been approved by the China Food and Drug Administration (CFDA).
On November 30, 2017, LifeTech (1302:HK) was given the "Best Investment Value Award for Listed Companies for the 13th Five-Year Plan Period" at the seventh session of the China Securities Golden Bauhinia Awards.
Recently, the well-known U.S. non-profit organization Heart of Hope Foundation has joined hands with LifeTech to provide international charitable medical aid at the Dos de Mayo Hospital in Peru, successfully performing interventional occlusion procedures on children with a congenital heart disease who are from a poor family in Peru.
On October 24, 2017, the Linzhi People's Hospital in Tibet successfully performed three minimally invasive interventional closure procedures for congenital heart diseases for the first time, filling the gap in the interventional treatment of congenital heart diseases in the city.
From October 7 to 8, 2017, the 8th Asia Pacific Congenital and Structural Heart Intervention Symposium 2017 (APCASH 2017) was held at the Hong Kong Convention and Exhibition Center.